title: MicroRNA profiling of human kidney cancer subtypes.
abstract: Although the functions of most of the identified microRNAs (miRNAs) have yet to be determined, their use as potential biomarkers has been considered in several human diseases and cancers. In order to understand their role in renal tumorigenesis, we screened the expression levels of miRNAs in four subtypes of human renal neoplasms: clear cell, papillary, and chromophobe renal cell carcinomas (RCC) as well as benign renal oncocytomas. We found a unique miRNA signature for each subtype of renal tumor. Furthermore, we identified unique patterns of miRNA expression distinguishing clear cell RCC cases with favorable vs. unfavorable outcome. Specifically, we documented the overexpression of miRs 424 and 203 in clear cell RCC relative to papillary RCC, as well as the inversion of expression of miR-203 in the benign oncocytomas (where it is underexpressed relative to normal kidney) as compared to the malignant chromophobe RCC (where it is overexpressed relative to normal kidney). Our results further suggest that overexpression of S-has-miR-32 is associated with poor outcome. While previous studies have identified unique miRNA expression pattern distinguishing tumors from different anatomical locations, here we extend this principle to demonstrate the utility of miRNA expression profiling to identify a signature unique to various tumor subtypes at a single anatomic locus.
authors.affiliation: Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. bin.teh@vai.org
authors.forename: David
authors.initials: D
authors.lastname: Petillo
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Kort
authors.forename: John
authors.initials: J
authors.lastname: Anema
authors.forename: Kyle A
authors.initials: KA
authors.lastname: Furge
authors.forename: Ximing J
authors.initials: XJ
authors.lastname: Yang
authors.forename: Bin Tean
authors.initials: BT
authors.lastname: Teh
mesh_terms: D018249:Adenoma, Oxyphilic / Q000235:genetics* / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000473:pathology; D016000:Cluster Analysis; D020869:Gene Expression Profiling / Q000379:methods*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics* / Q000473:pathology; D035683:MicroRNAs / Q000032:analysis*; D011379:Prognosis
chemical_list: D035683:MicroRNAs